Welcome to our dedicated page for British American Tobacco SEC filings (Ticker: BTAFF), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The BTAFF SEC filings page on Stock Titan provides access to regulatory documents filed by British American Tobacco p.l.c. as a foreign issuer under the Securities Exchange Act of 1934. The company indicates in its Form 6-K submissions that it files annual reports on Form 20-F, and it regularly furnishes Form 6-K current reports that attach press releases and other materials made available to investors.
Through this page, users can review 6-K filings that cover a range of topics: voting rights and capital, numerous “Transaction in own shares” announcements, an “Extension of Share Buyback Programme”, and a press release titled “On track for FY25 delivery; Reaffirming 2026 guidance and announcing a £1.3bn share buy-back”. These filings help investors understand how British American Tobacco p.l.c. manages its capital structure and communicates share buyback activity.
Other important filings include notifications made in accordance with UK Listing Rule 6.4.9R(2), and exhibits titled “Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them”. These documents are relevant for users interested in transactions by persons discharging managerial responsibilities and related parties. The filings also reference quarterly dividend information and payment details for specific periods, as well as press releases on proposed and completed block trades in ITC Hotels shares.
Certain Form 6-K filings state that the information in an exhibit is incorporated by reference into existing Form S-8 and Form F-3 registration statements for British American Tobacco p.l.c. and related issuers. On Stock Titan, AI-powered tools can help summarize these lengthy filings, highlight key sections, and make it easier to interpret complex disclosures around capital, governance notifications, and registration statement references.
Investors using this page can quickly locate the latest 6-K submissions, review historical filings, and examine disclosures related to share buybacks, voting rights, dividends, and transactions by persons discharging managerial responsibilities for BTAFF-linked British American Tobacco p.l.c. securities.
British American Tobacco p.l.c. reports a series of routine capital and governance updates, mainly focused on share buybacks and small executive share acquisitions. Under its existing buyback programme, the company repurchased 125,526 shares on 30 January 2026 at a volume‑weighted average price of 4,355.1405p, with further daily purchases including 108,725 shares on 2 February, 117,545 on 3 February, 136,167 on 4 February, 121,668 on 5 February and 131,297 on 6 February 2026. These shares are intended to be cancelled, leaving 2,176,273,303 ordinary shares in issue excluding treasury after the 6 February trades, while 132,976,327 shares are held in treasury. A separate voting rights notice states that, as at 30 January 2026, issued share capital with voting rights totalled 2,177,145,903 shares. Several senior executives and other managers acquired small numbers of shares, typically between 1 and 699 shares each, through the Share Incentive Plan, dividend reinvestment arrangements and deferred bonus schemes at prices around £45–£46 per share.
British American Tobacco p.l.c. has furnished a Form 6-K to provide investors with a press release titled “BAT to Present at CAGNY; Reaffirming 2026 Full-Year Guidance” dated February 18, 2026. The filing mainly notifies the market of the upcoming CAGNY presentation and confirms that the company is maintaining its previously issued 2026 full-year outlook.
British American Tobacco p.l.c. filed a Form 6-K to notify investors that its Annual Report for the year ended 31 December 2025 has been published. The filing, dated 13 February 2026, points to a press release describing the availability of this annual report.
The company uses this submission, made as a foreign private issuer under the Exchange Act, to formally provide U.S. investors access to the same annual reporting materials made available in its home market.
British American Tobacco p.l.c. submitted a Form 6-K as a foreign private issuer, dated February 13, 2026, under Rules 13a-16 and 15d-16 of the Exchange Act. The submission makes available, as an exhibit, the company’s Annual Report for the year ended 31 December 2025.
British American Tobacco p.l.c. files its 2025 Form 20‑F, describing its global tobacco and nicotine business, New Categories strategy and governance under IFRS with KPMG as auditor. The company lists American Depositary Shares and multiple long-dated notes on the New York Stock Exchange and reports 2,312,454,501 ordinary shares outstanding as of year-end.
The filing focuses heavily on risk factors, including competition from illicit trade, geopolitical instability, cyber and digital threats, complex supply chains, climate and circularity pressures, and pandemics. It also highlights extensive regulatory and taxation uncertainty for combustible, smokeless and Beyond Nicotine products, significant litigation and tax exposure, and the importance of talent retention, transformation programs and major ERP migration to support its multi-category growth plans.
British American Tobacco p.l.c. submitted a Form 6-K as a foreign private issuer, providing U.S. investors with information it has released in its home market. The filing, dated February 12, 2026, furnishes a press release titled “Share Buyback Programme.”
The exhibit indicates the company is formally communicating details of a share buyback programme, though this excerpt does not include the financial terms or size of the programme itself. The report is signed on behalf of British American Tobacco by Senior Assistant Company Secretary Nancy Jiang.
British American Tobacco reported mixed 2025 results, with modest underlying growth and heavy Canada-related cash outflows. Group revenue was £25,610 million, down 1.0% reported but up 2.1% at constant currency, driven by combustibles and strong Modern Oral growth, partly offset by weakness in APMEA.
New Categories revenue reached £3,621 million, up 7.0% at constant rates, with smokeless products now 18.2% of total revenue and 34.1 million consumers, up 4.7 million. Adjusted profit from operations as adjusted for Canada rose 2.3% to £11,628 million, while adjusted diluted EPS as adjusted for Canada grew 3.4% at constant rates to 352.8p.
Reported diluted EPS surged 157% to 349.1p, mainly from lower adjusting items including changes to the Canadian litigation provision. Cash generation fell as net cash from operating activities dropped 37.4% to £6,342 million and free cash flow before dividends declined 48.8%, reflecting a £2.6 billion Canada settlement payment and U.S. tax deferrals. Despite this, leverage was 2.48x adjusted net debt/adjusted EBITDA (2.55x as adjusted for Canada), with a target of 2.0–2.5x by end 2026. The dividend increased 2.0% to 245.04p and the company plans a £1.3 billion share buy-back in 2026, while guiding that 2026 performance will likely be at the lower end of its mid-term growth ranges.
British American Tobacco p.l.c. has filed a Form 6-K to furnish a press release titled “British American Tobacco p.l.c. (the “Company” or “BAT”) - Board Update – Chair Extension and Senior Independent Director Appointment,” dated February 10, 2026.
The materials in this report, including the press release, are incorporated by reference into the company’s existing Form S-8 and Form F-3 registration statements and related prospectuses.
British American Tobacco p.l.c. filed a Form 6-K summarizing several January 2026 press releases on share-related matters and disclosures by senior managers. The filing also includes a Schedule 5 blocklisting six monthly return for its Sharesave Schemes.
For the period from 1 July 2025 to 31 December 2025, under Sharesave Scheme A, the company issued 38,298 ordinary shares of 25p each, leaving 74,993 shares still available under that blocklisting. Sharesave Scheme B had no shares issued in the period and retained its full 1,500,000 share balance.
As of the end of the period, British American Tobacco reported 2,312,454,501 ordinary shares of 25p each in issue, including 132,988,352 shares held in treasury.